Artificial Cells: Perspective on Reconstructing Biological Cells and “Out of the Box” Innovations
ChemBioChem · 26.06.2026 · 27 (12)
DOI: 10.1002/cbic.202500933 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, online erschienen am 17.06.2026. Verfasst von Thomas Ming Swi Chang. Beteiligte Einrichtung: Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine & Biomedical Science…. Hauptthemen laut MEDLINE: Artificial Cells, Erythrocytes. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Virage Centre of Excellence in High Technology award, McGill University Advancement Program.
Abstract (Originalsprache)
The first artificial cell (Chang 1957, 1964) was in the form of artificial red blood cells (RBCs), one of the most important cells because all cells, tissues, organs, and indeed the human being need it for survival. I first reconstructed artificial RBCs in vitro. This is made of cellular dimensions with ultrathin membranes of polymer, crosslinked protein, protein–lipid, or lipid. The next step in this work is to develop this for actual use to replace RBCs in the body. This is a more complex task requiring modifying the configuration and dimensions. Instead of starting with all three functions, a bottom‐up approach is used. First, one with only oxygen transport function shows promising results in clinical trials with patients. A future direction is the development of artificial cells that have all three red blood cell functions including antioxidant, oxygen, and CO 2 transport. My research group has also been doing innovative research going outside the box of RBCs. This way, extensive variations in contents, membranes, dimensions, and configurations are possible. This allows for worldwide and innovative applications that encompass hemoperfusion, delivery systems, COVID‐19 vaccines, cancer therapy, therapy for hereditary enzyme defects like phenylketonuria, cell/stem cell therapy, microbes, nanomedicine, biotherapeutics, gene therapy, regenerative medicine, agricultural applications, aquatic culture, fermentation, nanorobotics, and other areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine & Biomedical Sciences, McGill University, Montreal, Quebec, Canada.
ORCID-Profile: Thomas Ming Swi Chang
Förderung
- Virage Centre of Excellence in High Technology award, McGill University Advancement Program
Zitieren
APA
Chang, T. M. S. (2026). Artificial Cells: Perspective on Reconstructing Biological Cells and “Out of the Box” Innovations. ChemBioChem, 27(12). https://doi.org/10.1002/cbic.202500933
Vancouver
Chang TMS. Artificial Cells: Perspective on Reconstructing Biological Cells and “Out of the Box” Innovations. ChemBioChem. 2026;27(12). doi:10.1002/cbic.202500933
BibTeX
@article{Chang2026,
author = {Chang, Thomas Ming Swi},
title = {Artificial Cells: Perspective on Reconstructing Biological Cells and “Out of the Box” Innovations},
journal = {ChemBioChem},
year = {2026},
volume = {27},
number = {12},
doi = {10.1002/cbic.202500933}
}
EUVIMED